Enhancement of G2 checkpoint function by gelsolin transfection in human cancer cells

Experimental Cell Research

Volumn 251, Issue 1, 1999, Pages 224-233

  Sakai, Norio ^a   Ohtsu, Makoto ^a   Fujita, Hisakazu ^a   Koike, Takao ^a   Kuzumaki, Noboru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cyclin B1; Diacylglycerol; G2 checkpoint function; Gelsolin; Ultraviolet C

Indexed keywords

CAFFEINE; CYCLIN B1; GELSOLIN;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID METABOLISM; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION CARCINOGENESIS; STOMACH CANCER; ULTRAVIOLET C RADIATION;

EID: 0033603866     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4552     Document Type: Article

References (45)

1. Moriya S., Yanagihara K., Fujita H., Kuzumaki N. Differential expression of HSP90, gelsolin and GST-π in human gastric carcinoma cell lines. Int. J. Oncol. 5:1994;1347-1351.
2. Tanaka M., Müllauer L., Ogiso Y., Fujita H., Moriya S., Furuuchi K., Harabayashi T., Shinohara N., Koyanagi T., Kuzumaki N. Gelsolin: A candidate for suppressor of human bladder cancer. Cancer Res. 55:1995;3228-3232.
3. Hartwell L. H., Kastan M. B. Cell cycle control and cancer. Science. 266:1994;1821-1828.
4. Kaufmann W. K., Paules R. S. DNA damage and cell cycle checkpoints. FASEB J. 10:1996;238-247.
5. El-Deiry W. S., Harper J. W., O'Connor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y., Wiman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W., Vogelstein B. Waf1/Cip1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
6. Baeg G. H., Matsumine A., Kuroda T., Bhattacharjee R. N., Miyashiro I., Toyoshima K., Akiyama T. The tumor suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J. 14:1995;5618-5625.
7. Savitsky K., Sfez S., Tagle D. A., Ziv Y., Sartiel A., Collins F. S., Shiloh Y., Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4:1995;2025-2032.
8. 2+-activated regulatory protein of macrophages. J. Biol. Chem. 255:1980;9490-9493.
9. Janmey P. A., Stossel T. P. Modulation and gelsolin function by phosphatidylinositol 4,5-bisphosphate. Nature. 325:1987;362-364.
10. Kwiatkowski D. J. Predominant induction of gelsolin and actin-binding protein during myeloid differentiation. J. Biol. Chem. 263:1988;13857-13862.
11. Dieffenbach C. W., SenGupta D. N., Krause D., Sawzak D., Silverman R. H. Cloning of murine gelsolin and its regulation during differentiation of embryonal carcinoma cells. J. Biol. Chem. 264:1989;13281-13288.
12. Müllauer L., Fujita H., Ishizaki A., Kuzumaki N. Tumor-suppressive function of mutated gelsolin in ras-transformed cells. Oncogene. 8:1993;2531-2536.
13. Furuuchi K., Fujita H., Tanaka M., Shichinohe T., Senmaru N., Ogiso Y., Moriya S., Hamada M., Kato H., Kuzumaki N. Gelsolin as a suppressor of malignant phenotype in human colon cancer. Tumor Targeting. 2:1996;277-283.
14. Dosaka-Akita H., Hommura F., Fujita H., Kinoshita I., Nishi M., Morikawa T., Katoh H., Kawakami Y., Kuzumaki N. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res. 58:1997;322-327.
15. Asch H. L., Head K., Dong Y., Natoli F., Winston J. S., Connolly J. L., Asch B. B. Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res. 56:1996;4841-4845.
16. Tahara E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 119:1993;265-272.
17. Getzenberg R. H., Konety B. R., Oeler T. A., Quigley M. M., Hakam A., Becich M. J., Bahnson R. R. Bladder cancer-associated nuclear matrix proteins. Cancer Res. 56:1996;1690-1694.
18. 2+-independent pathways. J. Exp. Med. 165:1987;97-106.
19. Lind S. E., Janmey P. A., Chaponnier C., Herbert T. J., Stossel T. P. Reversible binding of actin to gelsolin and profilin in human platelet extracts. J. Cell Biol. 105:1987;833-842.
20. Fujita H., Laham L. E., Janmey P. A., Kwiatkowski D. J., Stossel T. P., Banno Y., Nozawa Y., Müllauer L., Ishizaki A., Kuzumaki N. Function of [His 321] gelsolin isolated from a flat revertant of ras-transformed cells. Eur. J. Biochem. 229:1995;615-620.
21. Preiss J., Loomis C. R., Bishop W. R., Stein R., Niedel J. E., Bell R. M. Quantitative measurement of sn-1, 3-diacylglycerols present in platelets, hepatocytes and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261:1986;8597-8600.
22. Downes C. S., Musk S. R. R., Watson J. V., Johnson R. T. Caffeine overcomes a restriction point associated with DNA replication, but does not accelerate mitosis. J. Cell Biol. 110:1990;1855-1859.
23. Maity A., McKenna W. G., Muschel R. J. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother. Oncol. 31:1994;1-13.
24. Banno Y., Nakashima T., Kumada T., Ebisawa K., Nonomura Y., Nozawa Y. Effects of gelsolin on human platelet cytosolic phosphoinositide-phospholipase C isozymes. J. Biol. Chem. 267:1992;6488-6494.
25. Orren D. K., Petersen L. N., Bohr V. A. A. UV-responsive G2 checkpoint in rodent cells. Mol. Cell. Biol. 15:1995;3722-3730.
26. Davies H. E., Court J. B. Cycle delay in irradiated cytochalasin-induced polykaryons. Does cytoskeleton status affect cell cycle checkpoints? Cell Biol. Int. 19:1995;17-23.
27. Janmey P. A., Stossel T. P. Modulation of gelsolin function by phosphatidylinositol 4,5-bisphosphate. Nature. 325:1987;362-364.
28. Yonezawa N., Nishida E., Iida K., Yahara I., Sakai H. Inhibition of the interaction of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides. J. Biol. Chem. 265:1990;8382-8386.
29. Fukami K., Endo T., Imamura M., Takenawa T. Alpha-actinin and vinculin are PIP2-binding proteins involved in signaling by tyrosine kinase. J. Biol. Chem. 269:1994;1518-1522.
30. Lee S. B., Rhee S. G. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. Curr. Opin. Cell Biol. 7:1995;183-189.
31. Kim J. H., Suh Y. J., Lee T. G., Kim Y., Bae S. S., Kim M. J., Lambeth J. D., Suh P.-G., Ryu S. H. Inhibition of phospholipase D by a protein factor from bovine brain cytosol. J. Biol. Chem. 271:1996;25213-25219.
32. Sun H., Lin K., Yin H. L. Gelsolin modulates phospholipase C activity in vivo through phospholipid binding. J. Cell Biol. 138:1997;811-820.
33. Hammond S. M., Altshuller Y. M., Sung T.-C., Rudge S. A., Rose K., Engebrecht J., Morris A. J., Frohmann M. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J. Biol. Chem. 270:1995;29640-29643.
34. Hammond S. M., Jenco J. M., Nakashima S., Cadwallader K., Gu Q., Cook S., Nozawa Y., Prestwich G. D., Morris A. J., Frohman M. A., Morris A. J. Characterization of two alternately spliced form of phospholipase D1. J. Biol. Chem. 272:1997;3860-3868.
35. Azuma T., Witke W., Stossel T. P., Hartwig J. H., Kwiatkowski D. J. Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J. 17:1998;1362-1370.
36. Billah M. M., Anthes J. C. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J. 269:1990;281-291.
37. Carsberg C. J., Ohanian J., Friedmann P. S. Ultraviolet radiation stimulates a biphasic pattern of 1,2-diacylglycerol formation in cultured human melanocytes and keratinocytes by activation of phospholipase C and D. Biochem. J. 305:1995;471-477.
38. Sun B., Murray N. R., Field A. P. A role for nuclear phosphatidylinositol-specific phospholipase C in the G2/M phase transition. J. Biol. Chem. 1997.
39. Sakane F., Kanoh H. Molecules in focus: Diacylglycerol kinase. Int. J. Biochem. Cell Biol. 29:1997;1139-1143.
40. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:1995;484-496.
41. Daniel D. F., Shraga S., Etta L. The role of protein kinase C in G1 and G2/M phases of the cell cycle. Int. J. Oncol. 12:1997;181-186.
42. Hofmann J., O'Connor P. M., Jackman J., Schubert C., Ueberall F., Kohn K. W., Grunicke H. The protein kinase C inhibitor ilmofosine (BM 41440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents. Biochem. Biophys. Res. Commun. 199:1994;937-943.
43. Haas-Kogan D. A., Kogan S. C., Levi D., Dazin P., T'Ang A., Fung Y. K., Israel M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:1995;461-472.
44. Kaufmann W. K. Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer Metastasis Rev. 14:1995;31-41.
45. Lepley D. M., Li B., Birt D. F., Pelling J. C. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis. 17:1996;2367-2375.